Abbott Labs (ABT) PT Raised to $132 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures sink as Amazon, Intel intensify AI spending fears
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $104.57 --0%
Rating Summary:
26 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 39 | New: 7
Rating Summary:
26 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 39 | New: 7
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Abbott Labs (NYSE: ABT) to $132.00 (from $127.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Argus Downgrades Abbott Labs (ABT) to Hold
- eBay (EBAY) PT Raised to $125 at Susquehanna
- Isetan Mitsukoshi Holdings Ltd (3099:JP) (IMHDF) PT Raised to JPY2,250 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
